Holen Sie sich die Stockscreener-App
1.16
4.98%
0.055
Handel nachbörslich:
1.16
Schlusskurs vom Vortag:
$1.105
Offen:
$1.1
24-Stunden-Volumen:
31,500
Relative Volume:
0.82
Marktkapitalisierung:
$13.43M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.1887
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
+4.98%
1M Leistung:
-1.69%
6M Leistung:
+12.62%
1J Leistung:
-32.16%
1-Tages-Spanne:
$1.0801
$1.16
1-Wochen-Bereich:
$1.055
$1.16
52-Wochen-Spanne:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.16 | 12.79M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.96B | 957.25M | 5.31B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.26B | 1.98B | 0 | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Can volume confirm reversal in TherapeuticsMD Inc.Recession Risk & Technical Pattern Recognition Alerts - Newser
Using fundamentals and technicals on TherapeuticsMD Inc.2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
What makes TherapeuticsMD Inc. stock price move sharplyJuly 2025 Institutional & Consistent Profit Alerts - Newser
TherapeuticsMD: Q2 Earnings Snapshot - New Haven Register
Published on: 2025-08-13 05:39:11 - Newser
Will TherapeuticsMD Inc. rebound enough to break evenJuly 2025 Update & AI Driven Price Predictions - Newser
TherapeuticsMD Reports Q2 Profitability, Exceeding 2024 Results - AInvest
TherapeuticsMD Announces Second Quarter 2025 Financial Results - BioSpace
Has TherapeuticsMD Inc. formed a bullish divergence [2025 Winners & Losers]Daily Volume Surge Signals - Newser
TherapeuticsMD Swings to Profit in Q2 - AOL.com
Does TherapeuticsMD Inc. qualify in momentum factor screening2025 Top Decliners & Reliable Price Breakout Alerts - Newser
Signal strength of TherapeuticsMD Inc. stock in tech scannersHigh Confidence Strategy with Trend Alignment - Newser
TherapeuticsMD Inc. Rebounds From Oversold Zone — Now WhatConsistent Income Focused Trade List Analyzed - beatles.ru
TherapeuticsMD Reports Q2 2025 Financial Results - TipRanks
How to interpret RSI for TherapeuticsMD Inc. stockDay Trading Setup and Momentum Analysis - Newser
Using flow based indicators on TherapeuticsMD Inc.Price Spike Prediction for Active Traders - Newser
TherapeuticsMD, Inc. SEC 10-Q Report - TradingView
Market reaction to TherapeuticsMD Inc.’s recent newsWeekly Stock Movement Prediction Watchlist - Newser
Regression analysis insights on TherapeuticsMD Inc. performanceStable Swing Setup with Safety Analysis - Newser
Published on: 2025-08-11 03:11:11 - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutLow Drawdown Stock Screener with Analysis - Newser
Published on: 2025-08-11 00:15:37 - Newser
How TherapeuticsMD Inc. stock performs during market volatilityFree Low Risk Equity Screener With Results - Newser
Developing predictive dashboards with TherapeuticsMD Inc. dataBuy List With Technical Entry Triggers - Newser
What recovery options are there for TherapeuticsMD Inc.Free High Growth Low Risk Stock Selection - Newser
What to expect from TherapeuticsMD Inc. in the next 30 daysTrend Confirmation Scanner with Entry Focus - Newser
Is TherapeuticsMD Inc. stock bottoming outShort-Term Price Breakout Signal Analysis - Newser
Therapeuticsmd TXMD 2025Q2 Earnings Preview Upside Potential on New Product Launch - AInvest
Tools to monitor TherapeuticsMD Inc. recovery probabilityROI Focused Watchlist with Trade Confidence - Newser
Why TherapeuticsMD Inc. is moving todayInvestment Position Summary with Timeframe Forecast - Newser
Visual trend scoring systems applied to TherapeuticsMD Inc.Investment Timeline and ROI Summary Report - Newser
TherapeuticsMD (NASDAQ:TXMD) Stock Price Up 0.5% – Should You Buy? - Defense World
TherapeuticsMD Inc. stock trend forecastTechnical Setup Guide for Daily Watchlist - Newser
Will TherapeuticsMD Inc. see short term momentumDaily Breakout List with Smart Filters - Newser
TherapeuticsMD Inc. Company’s Quarterly Earnings Growth: What the Numbers SayTechnical Confirmation System with Signal Alerts - Newser
Traders Watching For Reversal Pattern in TherapeuticsMD Inc.Intraday Trade Ideas - beatles.ru
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):